STOCK TITAN

JATT II Acquisition: Great Point reports 6.41% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

JATT II Acquisition Corp. (JATT) is the subject of an amended Schedule 13G in which Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl each report shared voting and dispositive power over the same 500,000 ordinary shares, equal to 6.41% of the class. They may be deemed beneficial owners through Great Point’s investment-management role and their stated authority, but each disclaims beneficial ownership except to the extent of their respective pecuniary interests.

Shared beneficial ownership reported by each reporting person 500,000 ordinary shares The reporting persons report the same block; the amounts are not additive.
Class ownership percentage 6.41% Percentage reported for the 500,000-share block.
Shares outstanding 7,800,000 shares Issuer-reported count cited as the denominator for the reported ownership percentage; from the Form 10-Q filed August 13, 2026.
BVF shares held of record 330,000 shares Held by Biomedical Value Fund, L.P.
BOVF shares held of record 170,000 shares Held by Biomedical Offshore Value Fund, Ltd.
beneficial owner regulatory
"may be deemed to be the beneficial owner of the BVF Shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Shared Voting Power regulatory
"Shared Voting Power 500,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 500,000.00"
pecuniary interests regulatory
"except to the extent of their respective pecuniary interests"
Joint Filing Agreement regulatory
"The Reporting Persons have entered into a Joint Filing Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JATT shares did the reporting persons report?

Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl each reported shared beneficial ownership of the same 500,000 ordinary shares, representing 6.41% of the class.

Which funds hold JATT shares of record?

Biomedical Value Fund, L.P. holds 330,000 shares of record, and Biomedical Offshore Value Fund, Ltd. holds 170,000 shares of record.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G50765109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Great Point Partners, LLC
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Date:11/16/2026
Dr. Jeffrey R. Jay, M.D.
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D
Date:11/16/2026
Ms. Lillian Nordahl
Signature:/s/ Ms. Lillian Nordahl
Name/Title:Ms. Lillian Nordahl
Date:11/16/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the SCHEDULE 13G to which this Exhibit is attached, and such SCHEDULE 13G is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such SCHEDULE 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Dated: November 16, 2026 Great Point Partners, LLC By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D., as Senior Managing Member Dr. Jeffrey R. Jay, M.D. By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D. Ms. Lillian Nordahl By: /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl

Keep reading